Last Updated on June 22, 2023

Cancer Drug Resistance- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: OAE Publishing Inc.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

3.30

SJR

 0.815

h-Index

 17

Rank

 5806

Important Details

Title Cancer Drug Resistance
Type of Publication Journal
Discipline Pharmacology (medical) (Q2); Cancer Research (Q3)
Impact Score 3.30
SCImago Journal Rank (SJR) 0.815
h-index 17
Overall Rank 5806
Publisher Name OAE Publishing Inc.
Publication Country United States
International Standard Serial Number (ISSN) 2578532X
Coverage and History 2018-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
807

About Cancer Drug Resistance


Cancer Drug Resistance is a journal published by OAE Publishing Inc.. This journal covers the area[s] related to Pharmacology (medical), Cancer Research, etc. The coverage history of this journal is as follows: 2018-2022. The rank of this journal is 5806. This journal's impact score, h-index, and SJR are 3.30, 17, and 0.815, respectively. The ISSN of this journal is/are as follows: 2578532X.

The best quartile of Cancer Drug Resistance is Q2. This journal has received a total of 807 citations during the last three years (Preceding 2022).


Cancer Drug Resistance Impact Score 2022-2023


The latest impact score (IS) of the Cancer Drug Resistance is 3.30. It is computed in the year 2023 as per its definition and based on Scopus data. 3.30

It is increased by a factor of around 0.32, and the percentage change is 10.74% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Cancer Drug Resistance Impact Score 2023


Impact Score 2022 of Cancer Drug Resistance is 3.30. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Cancer Drug Resistance. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.30
2021 2.98
2020 2.35
2019 1.50
2018 0.00

Cancer Drug Resistance h-index


  Table Setting

The h-index of Cancer Drug Resistance is 17. By definition of the h-index, this journal has at least 17 published articles with more than 17 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Cancer Drug Resistance ISSN


The International Standard Serial Number (ISSN) of Cancer Drug Resistance is/are as follows: 2578532X.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Cancer Drug Resistance Ranking and SCImago Journal Rank (SJR)


The Cancer Drug Resistance is ranked 5806 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.815.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Cancer Drug Resistance Publisher


Table Setting

The publisher of Cancer Drug Resistance is OAE Publishing Inc.. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2018-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


How to publish in Cancer Drug Resistance


If your area of research or discipline is related to Pharmacology (medical), Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Cancer Drug Resistance?

The latest impact score of Cancer Drug Resistance is 3.30. It is computed in the year 2023.


What is the h-index of Cancer Drug Resistance?

The latest h-index of Cancer Drug Resistance is 17. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Cancer Drug Resistance?

The latest SCImago Journal Rank (SJR) of Cancer Drug Resistance is 0.815. It is calculated in the year 2023.


What is the ranking of Cancer Drug Resistance?

The latest ranking of Cancer Drug Resistance is 5806. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Cancer Drug Resistance?

Cancer Drug Resistance is published by OAE Publishing Inc.. The publication country of this journal is United States.


What is the abbreviation of Cancer Drug Resistance?

This standard abbreviation of Cancer Drug Resistance is .


Is "Cancer Drug Resistance" a Journal, Conference or Book Series?

Cancer Drug Resistance is a journal published by OAE Publishing Inc..


What is the scope of Cancer Drug Resistance?

The scope of Cancer Drug Resistance is as follows:

  • Pharmacology (medical)
  • Cancer Research

For detailed scope of Cancer Drug Resistance, check the official website of this journal.


What is the ISSN of Cancer Drug Resistance?

The International Standard Serial Number (ISSN) of Cancer Drug Resistance is/are as follows: 2578532X.


What is the best quartile for Cancer Drug Resistance?

The best quartile for Cancer Drug Resistance is Q2.


What is the coverage history of Cancer Drug Resistance?

The coverage history of Cancer Drug Resistance is as follows 2018-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
Entrepreneurship Theory and Practice Journal Wiley-Blackwell 338 185 12.75
Marine Biology Research Journal Taylor and Francis Ltd. 13573 42 1.06
Studies in Continuing Education Journal Routledge 6011 38 2.81
Population Review Journal Sociological Demography Press 17841 13 0.73
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS Conference And Proceedings Association for Computing Machinery (ACM) 781 100 8.01
Proceedings of the International Semiconductor Conference, CAS Conference And Proceedings Institute of Electrical and Electronics Engineers Inc. 25734 16 0.00
Cuadernos de historia (Santiago, Chile) Journal Universidad de Chile 20081 4 0.25
Communications in Computational Physics Journal Global Science Press 3847 64 2.63
PLoS ONE Journal Public Library of Science 5108 404 3.75

Check complete list




Cancer Drug Resistance Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 3.30
2021 2.98
2020 2.35
2019 1.50
2018 0.00



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press | United Kingdom

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All